SARAJEVO (Bosnia and Herzegovina), January 28 (SeeNews) – U.S.-based pharmaceutical firm Alvogen Group is planning to buy a minority stake in Bosnian peer Bosnalijek and thus set foot in Europe, Bosnian media reported on Thursday.